Phospholipase A2, Group IIE (PLA2G2E) (Middle Region) Peptid

Details zu Produkt Nr. ABIN981824, Anbieter: Anmelden zum Anzeigen
Proteinname
  • GIIE sPLA2
  • sPLA2-IIE
  • phospholipase A2 group IIE
  • phospholipase A2, group IIE
  • PLA2G2E
  • Pla2g2e
Protein Region
Middle Region
Spezies
Human
1
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB)
Optionen
Hersteller
Anmelden zum Anzeigen
Hersteller Produkt- Nr.
Anmelden zum Anzeigen
Geblockter Antikörper anti-PLA2G2E Antikörper (Phospholipase A2, Group IIE) (Middle Region) (ABIN2782820)
Sequenz GIFCAGRTTC QRLTCECDKR AALCFRRNLG TYNRKYAHYP NKLCTGPTPP
Produktmerkmale This is a synthetic peptide designed for use in combination with anti-PLA2G2E Antibody(ARP47041_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
Reinigung Purified
Hintergrund PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides.PLA2G2E has a preference for arachidonic-containing phospholipids.

Alias Symbols: -

Protein Size: 142
Molekulargewicht 16 kDa
Gen-ID 30814
NCBI Accession NM_014589, NP_055404
UniProt Q9NZK7
Applikations-hinweise Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Lyophilized
Rekonstitution Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration 1 mg/mL
Buffer Final peptide concentration is 1 mg/mL in PBS.
Handhabung Avoid repeated freeze-thaw cycles.
Lagerung -20 °C
Informationen zur Lagerung For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.